NCT06897943 (EpGAr) is a clinical trial in Gonococcal (GC) Infection, sponsored by University Hospital, Brest.

Who is sponsoring NCT06897943?

NCT06897943 is sponsored by University Hospital, Brest.

What condition does NCT06897943 study?

NCT06897943 studies Gonococcal (GC) Infection, Arthritis, Infectious.

Is NCT06897943 still recruiting?

NCT06897943 is currently recruiting now. Last updated 27 March 2025.

Last reviewed 2025-03-27 · How we verify

NCT06897943: EpGAr

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Epidemiology of Gonococcal Arthritis (EpGAr)

Recruiting now Last updated 27 March 2025

What this trial tests

trial in Gonococcal (GC) Infection in 11 participants. Currently enrolling.

Timeline

1 December 2024

Primary endpoint
30 April 2025

30 April 2025

Quick facts

Lead sponsor	University Hospital, Brest
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	11
Start date	1 December 2024
Primary completion	30 April 2025
Estimated completion	30 April 2025
Sites	2 locations across France

Conditions studied

Gonococcal (GC) Infection — all drugs for Gonococcal (GC) Infection →
Arthritis, Infectious — all drugs for Arthritis, Infectious →

Sponsor

University Hospital, Brest

Who can join

Eligibility, any sex, with Gonococcal (GC) Infection or Arthritis, Infectious. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this retrospective observational study was to describe the epidemiology of Neisseria gonorrhoeae septic arthritis over the last 10 years at Brest and Rennes university hospitals. The main question is whether there are any risk factors based on the epidemiological and clinical data on these cases. The second objective is to characterize the gonococcal strains isolated in order to determine whether there is a common clone, a virulence factor or specific resistance genes.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other University Hospital, Brest trials

Trials by the same sponsor.

NCT07526688 — Aerobic Physical Activity and Orofacial Myofascial Pain · NA · not yet recruiting
NCT07487155 — Unified Junction of Care, Integrated Treatments and Team Coordination for ADHD in Prison Settings With Substance Use Dis · NA · not yet recruiting
NCT07417605 — Diagnostic Performance Of 4D Dynamic LAFOV FDG-PET Acquisition for Differentiation of Residual Disease and Post-radiatio · not yet recruiting
NCT07302074 — Understanding of Rare Inflammatory Arthritis in Comparison to Classical Inflammatory Arthritis : Tissular Observations a · NA · recruiting
NCT06441773 — Impact of Respiratory Rehabilitation on Quality of Life in Patients With Metastatic Non-small Cell Lung Cancer Treated W · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06897943 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Brest
Last refreshed: 27 March 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06897943.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing